Moreover, the decreased expression levels of GILZ and FKBP5 and increased IL-1β protein levels at the basal state in T2D patients compared to healthy individuals, further supported the deficiency of GR signaling and revealed GC-resistance in PBMCs of T2D patients. This evidence concerns the gene IL1B and type 2 diabetes mellitus.